Use of proteins and peptides of the TGF-beta superfamily for purification and therapeutic methods

Details for Australian Patent Application No. 2007254824 (hide)

Owner Wyeth

Inventors Zhang, Jimin; Brown, Christopher Todd; Shen, Emily Sheng-Ming; Lu, Zhijian; Yaworsky, Paul John; Olland, Stephane H.; Liu, Wei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007254824

PCT Pub. Number WO2007/143161

Priority 60/810,798 02.06.06 US

Filing date 1 June 2007

Wipo publication date 13 December 2007

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

C07K 1/22 (2006.01) General processes for the preparation of peptides

C07K 14/495 (2006.01) Peptides having more than 20 amino acids

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

C07K 17/02 (2006.01) Carrier-bound or immobilised peptides

G01N 33/543 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with an insoluble carrier for immobilising immunochemicals

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/143161 Priority application(s): WO2007/143161

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254826-Pharmaceutical compositions for sustained release of phenyephrine

2007254821-Sustained release pharmaceutical formulation comprising phenylephrine